NATALIA DE LAS
HERAS JIMÉNEZ
Profesora titular de universidad
Hospital de Jerez
Jerez, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Jerez (8)
2024
-
Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis
Leukemia
-
Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib
Annals of Hematology
-
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis
American Journal of Hematology
2023
2022
-
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270
2017
-
Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL
European Journal of Haematology, Vol. 98, Núm. 2, pp. 142-148
-
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
British Journal of Cancer, Vol. 117, Núm. 2, pp. 256-265
2015
-
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433